主动脉腔内修复术后植入后综合征危险因素与结局的系统评价
该系统评价纳入31项研究、2847例肾下腹主动脉瘤腔内修复患者,汇总植入后综合征发生率为25.3%。聚酯移植物较聚四氟乙烯移植物与植入后综合征风险更高相关(94.8% vs 3.7%,P=.0001),植入后综合征组30天死亡率和主要不良心脏事件发生率均显著更高。
要点
- 植入后综合征汇总发生率为25.3%,聚酯移植物组与植入后综合征风险更高相关(94.8% vs 3.7%,P=.0001)。
- 植入后综合征组30天死亡率0.6% vs 无植入后综合征组0%(P=.03),主要不良心脏事件5.8% vs 0.43%(P<.0001)。
- 作者认为可考虑选用聚四氟乙烯移植物替代聚酯移植物以减少植入后综合征发生。
核心结论
- 该系统评价提示聚酯移植物较聚四氟乙烯移植物与植入后综合征强烈相关。
- 本报告提示植入后综合征与30天死亡率和主要不良心脏事件之间存在关联。
- 作者认为,鉴于这些临床后果,考虑使用聚四氟乙烯移植物替代聚酯移植物以减少植入后综合征发生率,可能是改善总体结局的简单步骤。
- 作者提出,进一步探索与植入后综合征相关的炎症介质与死亡率和心脏并发症之间的关系,可能加深对风险的理解,并最终减轻发生植入后综合征患者的伤害。
研究设计与样本
- 系统文献综述与分析按照PRISMA和Cochrane指南进行,检索PubMed、Scopus、ClinicalTrials.gov和Cochrane Central Register of Controlled Trials。
- 纳入关于肾下腹主动脉瘤腔内修复术后植入后综合征的英文研究,去除重复后共纳入31项研究。
- 共回顾2847例患者,平均年龄70.7岁,其中2012例(90.4%)为男性,汇总平均随访26.1个月。
主要发现
- 植入后综合征报告发生率为25.3%,平均动脉瘤直径56.4 cm。
- 聚四氟乙烯移植物用于794例患者(27.9%),聚酯移植物用于1839例(64.6%)。
- 术后白细胞计数、C反应蛋白、白细胞介素(IL)-6、IL-8和IL-10水平均显著升高。
- 30天结局包括I型内漏率0.8%、II型内漏率1.7%、再干预率0.35%、死亡率0.25%。
- 植入后综合征组(n=309)vs 无植入后综合征组(n=691)亚组汇总分析显示,聚酯移植物(n=642)较聚四氟乙烯移植物(n=234)与更高的植入后综合征发生率相关(94.8% vs 3.7%;P=.0001)。
关键数值与推荐
- 植入后综合征组术前白细胞计数7.61 vs 无植入后综合征组6.76 × 109/L(P=.04),术后15.0 vs 9.8 × 109/L(P=.0007)。
- 植入后综合征组术后IL-6水平98.6 vs 无植入后综合征组25.2 pg/mL(P=.02)。
- 动脉瘤直径及瘤囊内慢性或新发血栓量未被确定为植入后综合征的危险因素。
- 植入后综合征组 vs 无植入后综合征组30天死亡率0.6% vs 0%(P=.03),主要不良心脏事件5.8% vs 0.43%(P<.0001)。
- 植入后综合征组与无植入后综合征组在再干预或30天I型或II型内漏方面未见差异。
临床怎么用
- 作者认为,考虑使用聚四氟乙烯移植物替代聚酯移植物以减少植入后综合征发生率,可能是改善总体结局的简单步骤。
- 作者提出,进一步探索与植入后综合征相关的炎症介质与死亡率和心脏并发症之间的关系,可能加深对风险的理解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Post implantation syndrome (PIS) is an early systemic inflammatory response following endovascular aortic repair (EVAR). The response is variable in patients and the clinical significance of PIS upon outcomes is unknown. This study aims to evaluate the incidence, risk factors, and prognostic implication of PIS. METHODS: Systematic literature review and analysis was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) and Cochrane guidelines of PubMed, Scopus, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials. Eligible English-language studies regarding PIS after infrarenal EVAR were included, after removing duplicates. RESULTS: After screening, 31 studies were included. A total of 2847 patients were reviewed, with mean age of 70.7 years, of which 2012 (90.4%) were male, with a pooled mean follow-up of 26.1 months. PIS was reported in 25.3% of cases, with mean aneurysm diameter of 56.4 cm. Polytetrafluoroethylene (PTFE) grafts were utilized in 794 patients (27.9%) with polyester in 1839 (64.6%). White blood cell count, C-reactive protein, interleukin (IL)-6, IL-8, and IL-10 levels were all significantly elevated postoperatively. Thirty-day outcomes included type I endoleak rate of 0.8%, type II endoleak rate of 1.7%, reintervention rate of 0.35%, and mortality rate of 0.25%. Subgroup pooled analysis of patients with PIS (n = 309) vs No-PIS (n = 691) revealed that polyester (n = 642), rather than PTFE (n = 234) grafts, were associated with a higher rate of PIS (94.8% vs 3.7%; P = .0001), White blood cell count was higher in the PIS group both preoperatively (7.61 vs 6.76 × 109/L; P = .04) and postoperatively (15.0 vs 9.8 × 109/L; P = .0007) and IL-6 levels were higher in the PIS group postoperatively (98.6 vs 25.2 pg/mL; P = .02). Aneurysm diameter and amount of chronic or new thrombus within the aneurysm sac was not identified as a risk factor for PIS. Pooled outcomes of patients with PIS vs No-PIS demonstrated a significantly higher rate of 30-day mortality (0.6% vs 0%; P = .03) and major adverse cardiac events (5.8% vs 0.43%; P < .0001) without any differences seen in reintervention or 30-day type I or type II endoleaks. CONCLUSIONS: This systematic review suggests that polyester grafts are strongly associated with PIS compared with PTFE. Interestingly, this report is suggestive of an association between 30-day mortality and major adverse cardiac events and PIS. Given these clinical sequelae, consideration for use of PTFE over polyester grafts to reduce the incidence of PIS may be a simple step to improve overall outcome. Further, exploration of the relationship between inflammatory mediators associated with PIS and mortality and cardiac complications may engender deeper understanding of risks, leading to eventual mitigation of harm for patients experiencing PIS.
引用
- D'Oria M, Manoranjithan S, Scoville C, et al. Systematic review of risk factors and outcomes of post-implantation syndrome following endovascular aortic repair. J Vasc Surg. 2023. PMID: 38122858. doi:10.1016/j.jvs.2023.12.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。